Showing 1 - 8 results of 8 for search 'Steven K. Libutti', query time: 0.03s
Refine Results
-
1
-
2
Correction: Down-Regulation of amin Anteracting rotein -ike Is Associated with Promoter Methylation and an Invasive Phenotype in Breast, Colon, Lung and Pancreatic Cancers. by Mijung Kwon, Soo Jin Lee, Srilakshmi Reddy, Yevangelina Rybak, Asha Adem, Steven K. Libutti
Published 2013-01-01
Article -
3
Microarray Gene Expression Analysis of Murine Tumor Heterogeneity Defined by Dynamic Contrast-Enhanced MRI by Nick G. Costouros, Dominique Lorang, Yantian Zhang, Marshall S. Miller, Felix E. Diehn, Stephen M. Hewitt, Michael V. Knopp, King C. P. Li, Peter L. Choyke, H. Richard Alexander, Steven K. Libutti
Published 2002-07-01
Article -
4
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling by Joseph D Butner, Geoffrey V Martin, Zhihui Wang, Bruna Corradetti, Mauro Ferrari, Nestor Esnaola, Caroline Chung, David S Hong, James W Welsh, Naomi Hasegawa, Elizabeth A Mittendorf, Steven A Curley, Shu-Hsia Chen, Ping-Ying Pan, Steven K Libutti, Shridar Ganesan, Richard L Sidman, Renata Pasqualini, Wadih Arap, Eugene J Koay, Vittorio Cristini
Published 2021-11-01
Article -
5
A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection by Amit Singla, Nicholas B. Dadario, Ashima Singla, Patricia Greenberg, Rachel Yan, Anil Nanda, Detlev Boison, Rakesh Malhotra, Sunil Patel, Suri Nipun, Kaur Maninderpal, Dorothy Castro, Sanaa Bdiiwi, Hala Boktor, Htay Htay Kyi, Anne Sutherland, Amee Patrawalla, Kevin Ly, Yingda Xie, Ashish Sonig, Priyank Khandelwal, James Liu, Joseph Koziol, Diana Finkle, Sara Subanna, Steven K. Libutti
Published 2023-01-01
Article -
6
A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection. by Amit Singla, Nicholas B Dadario, Ashima Singla, Patricia Greenberg, Rachel Yan, Anil Nanda, Detlev Boison, Rakesh Malhotra, Sunil Patel, Suri Nipun, Kaur Maninderpal, Dorothy Castro, Sanaa Bdiiwi, Hala Boktor, Htay Htay Kyi, Anne Sutherland, Amee Patrawalla, Kevin Ly, Yingda Xie, Ashish Sonig, Priyank Khandelwal, James Liu, Joseph Koziol, Diana Finkle, Sara Subanna, Steven K Libutti
Published 2023-01-01
Article -
7
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer by Robert H. Shoemaker, Reynold A. Panettieri, Steven K. Libutti, Howard S. Hochster, Norman R. Watts, Paul T. Wingfield, Philipp Starkl, Lisabeth Pimenov, Riem Gawish, Anastasiya Hladik, Sylvia Knapp, Daniel Boring, Jonathan M. White, Quentin Lawrence, Jeremy Boone, Jason D. Marshall, Rebecca L. Matthews, Brian D. Cholewa, Jeffrey W. Richig, Ben T. Chen, David L. McCormick, Romana Gugensberger, Sonja Höller, Josef M. Penninger, Gerald Wirnsberger
Published 2022-01-01
Article -
8
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer. by Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, Howard S Hochster, Norman R Watts, Paul T Wingfield, Philipp Starkl, Lisabeth Pimenov, Riem Gawish, Anastasiya Hladik, Sylvia Knapp, Daniel Boring, Jonathan M White, Quentin Lawrence, Jeremy Boone, Jason D Marshall, Rebecca L Matthews, Brian D Cholewa, Jeffrey W Richig, Ben T Chen, David L McCormick, Romana Gugensberger, Sonja Höller, Josef M Penninger, Gerald Wirnsberger
Published 2022-01-01
Article